Relative Strength Index (RSI)

Search documents
Down 36.7% in 4 Weeks, Here's Why Summit Therapeutics (SMMT) Looks Ripe for a Turnaround
ZACKS· 2025-06-03 14:36
A downtrend has been apparent in Summit Therapeutics PLC (SMMT) lately with too much selling pressure. The stock has declined 36.7% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.How to Determine if a Stock is OversoldWe use Relative Strength Index (RSI), one of the most commonly used technical ind ...
Criteo (CRTO) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-06-02 14:36
Core Viewpoint - Criteo S.A. (CRTO) has experienced a significant downtrend, with a 13.6% decline in stock price over the past four weeks, but it is now in oversold territory, suggesting a potential turnaround due to analysts' positive earnings outlook [1][5][7] Group 1: Stock Performance - The stock has faced heavy selling pressure, leading to a decline of 13.6% in the last four weeks [1] - The Relative Strength Index (RSI) for CRTO is currently at 28.25, indicating that the stock is oversold [5] - Oversold stocks are often seen as potential entry points for investors looking for rebounds [3] Group 2: Analyst Sentiment - There is a strong consensus among sell-side analysts to raise earnings estimates for CRTO, resulting in a 6.6% increase in the consensus EPS estimate over the last 30 days [7] - A positive trend in earnings estimate revisions typically correlates with price appreciation in the near term [7] Group 3: Zacks Rank - CRTO holds a Zacks Rank of 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate trends and EPS surprises [8]
After Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA)
ZACKS· 2025-05-29 14:36
A downtrend has been apparent in Sera Prognostics, Inc. (SERA) lately with too much selling pressure. The stock has declined 43.9% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company's ability to report better earnings than they predicted earlier, the stock could be due for a turnaround.Here is How to Spot Oversold StocksWe use Relative Strength Index (RSI), one of the most commonly used technical indicato ...
2 Red-Hot Stocks With High RSIs and More Upside to Come
MarketBeat· 2025-05-27 18:24
Core Viewpoint - The Relative Strength Index (RSI) is a key momentum indicator, with readings above 70 indicating potential overbought conditions. However, in strong bull markets, stocks can remain overbought, particularly when institutional demand is high. Snowflake and Gap are highlighted as stocks with strong momentum and potential for further upside despite elevated RSI levels [1]. Group 1: Snowflake Inc. (NYSE: SNOW) - Snowflake's current RSI is at 75, with a 12-month price forecast of $217.33, indicating a 6.27% upside from the current price of $204.51 [2]. - The stock has increased by 65% since April and is trading at 52-week highs, having broken out of a multi-month range [2][3]. - The recent earnings report showed a 26% year-over-year increase in product revenue, reaching nearly $997 million, contributing to positive analyst sentiment [3][4]. - JMP Securities has reiterated a Buy rating with a new price target of $245, suggesting a potential 22% upside from current levels [5]. Group 2: Gap Inc. (NYSE: GPS) - Gap's RSI is at 74, with a 12-month price forecast of $28.20, indicating potential for further gains [6]. - The stock has also risen by 66% since April and is nearing its highest levels since summer 2024, approaching key resistance levels [7]. - Citigroup has reiterated a Buy rating and raised its price target to $33, reflecting confidence in Gap's operational improvements and margin retention amid rebounding consumer demand [8][9]. - Gap has demonstrated effective inventory and pricing discipline, outperforming in a volatile retail environment [9]. Group 3: Market Dynamics - High RSI readings do not necessarily indicate a reversal in trending markets, especially when supported by strong earnings and analyst upgrades. Snowflake and Gap exemplify this phenomenon [10]. - Both stocks have experienced over 65% gains in less than two months, suggesting potential for continued bullish sentiment if they maintain current levels [11].
UnitedHealth stock triggers strongest bullish signal in over 15 years
Finbold· 2025-05-27 08:39
Core Insights - UnitedHealth (NYSE: UNH) has experienced a significant decline in stock price, dropping nearly 30% from approximately $600 in early April to $295, marking a plunge into deeply oversold territory with a Relative Strength Index (RSI) of 27.78, a level not seen since the 2008 financial crisis [1][2][5] Group 1: Stock Performance and Technical Indicators - The RSI below 30 indicates that UNH is oversold and may be poised for a rebound, as seen in previous instances when the stock hit similar levels [2] - The stock has found some stability after an insider initiative to purchase a large number of shares, which has helped boost investor confidence [7] Group 2: Leadership and Regulatory Challenges - The troubles for UNH began with the abrupt resignation of CEO Andrew Witty on May 13, leading to the suspension of the company's 2025 financial outlook due to rising medical costs and increased demand for care [5][6] - Stephen Hemsley, former CEO, has returned to stabilize the company, expressing disappointment in recent performance but maintaining confidence in long-term growth [6] Group 3: Analyst Ratings and Market Sentiment - Truist has cut UnitedHealth's price target from $580 to $360 while maintaining a "Buy" rating, citing suspended guidance and leadership changes as key factors [7] - TD Cowen downgraded UNH to "Hold," reducing its target from $520 to $308, attributing this to coding pressures, regulatory changes, and ongoing investigations [8]
Down 18.4% in 4 Weeks, Here's Why You Should You Buy the Dip in P3 Health Partners (PIII)
ZACKS· 2025-05-26 14:35
Core Viewpoint - P3 Health Partners Inc. (PIII) is experiencing significant selling pressure, having declined 18.4% over the past four weeks, but is now positioned for a potential trend reversal as it is in oversold territory and analysts expect better earnings than previously predicted [1]. Group 1: Technical Analysis - The Relative Strength Index (RSI) is a key indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2]. - PIII's current RSI reading is 23.11, suggesting that the heavy selling pressure may be exhausting itself, indicating a potential trend reversal [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts that earnings estimates for PIII have increased by 7.8% over the last 30 days, which often correlates with price appreciation [7]. - PIII holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, further supporting the potential for a turnaround [8].
Oxford Square Capital (OXSQ) Loses 7.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
ZACKS· 2025-05-26 14:35
Core Viewpoint - Oxford Square Capital Corp. (OXSQ) is experiencing significant selling pressure, with a 7.5% decline over the past four weeks, but is positioned for a potential trend reversal due to being in oversold territory and positive earnings outlook from analysts [1]. Group 1: Technical Indicators - The Relative Strength Index (RSI) is a key technical indicator used to determine if a stock is oversold, with a reading below 30 typically indicating this condition [2]. - OXSQ's current RSI reading is 27.24, suggesting that the heavy selling may be exhausting itself and a trend reversal could be imminent [5]. Group 2: Fundamental Analysis - There is strong consensus among sell-side analysts that OXSQ will report better earnings than previously predicted, with the consensus EPS estimate increasing by 14.3% over the last 30 days [7]. - OXSQ holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises, indicating a strong potential for a turnaround [8].
After Plunging 10.87% in 4 Weeks, Here's Why the Trend Might Reverse for Cervecerias Unidas (CCU)
ZACKS· 2025-05-23 14:35
Group 1 - Cervecerias Unidas (CCU) has experienced significant selling pressure, resulting in a 10.9% decline in stock price over the past four weeks, but it is now considered to be in oversold territory with potential for recovery [1] - The Relative Strength Index (RSI) for CCU is currently at 27.06, indicating that the stock may be nearing a reversal point due to excessive selling [5] - Analysts have raised earnings estimates for CCU by 12.9% over the last 30 days, suggesting a positive outlook for the company's earnings and potential price appreciation [7] Group 2 - CCU holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks, which indicates a strong potential for a turnaround in the near term [8]
Snowflake Melts Resistance: Can Q1 Earnings Spark A Fresh Flurry Of Gains?
Benzinga· 2025-05-21 18:30
Core Viewpoint - Snowflake Inc. is poised to report its first quarter earnings with positive momentum, expecting earnings per share of 21 cents and revenue of $1.01 billion [1] Group 1: Stock Performance - The stock has increased by 10.84% over the past year but is down 14.50% year-to-date; however, it has surged 31.64% in the last month [1] - As of the latest publication, SNOW stock was trading at $181.04, reflecting a 1% decrease [4] Group 2: Technical Analysis - Snowflake stock has broken through major resistance levels and is above both medium and long-term moving averages, indicating a moderately bullish trend [2] - The Moving Average Convergence Divergence (MACD) indicator is at 7.82, supporting bullish sentiment, while the Relative Strength Index (RSI) is at 69.61, suggesting potential overbought conditions [3] Group 3: Analyst Ratings and Price Targets - Analysts maintain a Buy consensus rating with an average price target of $198.28, indicating a potential upside of 15.09% based on recent reports from JMP Securities, Jefferies, and Rosenblatt [4] - The average target from these reports is $208.67, suggesting further growth potential [4]
3 Resistance Trendlines Driving the S&P 500's Advance
Schaeffers Investment Research· 2025-05-19 12:55
Core Viewpoint - The recent bullish "outside day" candle on April 30 indicates a potential for upward price movement in the S&P 500 Index (SPX), supported by historical trends and current market sentiment [4][5]. Market Sentiment and Technical Analysis - The SPX closed above its year-end 2024 level for the first time since February 28, suggesting a shift in market dynamics [3]. - A significant gap above resistance levels was observed, driven by positive developments in U.S.-China trade talks, which traders did not fully discount [5]. - The SPX's recent rally has left it "overbought" according to the 14-day Relative Strength Index (RSI), indicating potential caution for future movements [6]. Resistance and Support Levels - Key resistance levels for the SPX include the 6,000 mark and just below 6,150, which is the all-time high from February [7][8]. - Potential support levels are identified at 5,882 (2024 close), 5,783 (Election Day close), and the 200-day moving average at 5,760 [15]. Market Dynamics and Investor Behavior - Low put open interest suggests reduced hedging among money managers, who are increasingly looking at overseas markets and alternative assets like gold [2]. - A notable decrease in the buy-to-open put/call volume ratio indicates a shift in sentiment among equity option buyers, moving closer to levels that have historically preceded market weakness [13][14].